Join the Osteoarthritis group to help and get support from people like you.
Osteoarthritis News (Page 3)
Related terms: Arthritis, Osteoarthritis, Degenerative Arthritis, Degenerative joint disease (DJD), Hypertrophic Osteoarthritis, Osteoarthrosis, DJD, OA, Degenerative Joint disease, Joint Pain, Gonarthrosis, Sacroiliac Arthritis
Washington State's New Payroll Tax Helps Fund Long-Term Care. Could It Be a Model for the Nation?
FRIDAY, July 14, 2023 – Vicki Bickford is a professional caregiver, but lately she’s been worried more and more about her own aging. Bickford, 66, has aggressive arthritis that has required hip r...
Got Arthritis Pain? What State You Live In May Matter
WEDNESDAY, July 12, 2023 – If you live in West Virginia you’re more likely to experience joint pain due to arthritis, according to a new study that looked at the differences in pain across states. “...
Want a Healthier, Happier Old Age? Get Moving
MONDAY, July 10, 2023 – The couch potato life may not be a happy one. When older adults become more sedentary, their overall quality of life takes a hit, new research cautions. Sitting still is your...
Low-Dose Colchicine Might Prevent or Delay Knee, Hip Replacements
WEDNESDAY, May 31, 2023 – An anti-inflammatory drug that has been around for over 2,000 years might help delay a very modern problem: hip and knee replacements. That's the suggestion of a new study...
When Arthritis Strikes, Keep Moving
MONDAY, May 29, 2023 – Your achy joints may suggest that you take it easy. Don’t listen to them, experts say. If it hurts when you get up from a chair or climb stairs, you might have osteoarthritis. ...
FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain
TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) – Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration...
FDA Medwatch Alert: Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems
ISSUE: The U.S. Food and Drug Administration is investigating serious adverse events involving Limbrel, a product in capsule form currently being marketed as a medical food to manage the metabolic...
Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis Knee Pain
BURLINGTON, Mass., Oct. 06, 2017 (GLOBE NEWSWIRE) – Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug Administration (FDA) approved Zilretta (triamcinolone...
FDA Approves Vivlodex (meloxicam) for Osteoarthritis Pain
PHILADELPHIA, October 23, 2015 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the United States Food and ...
Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain
PHILADELPHIA, August 25, 2014 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today the United States Food and Drug A...
FDA Medwatch Alert: Super Arthgold by Nano Well-being Health: Recall - Undeclared Drug Ingredients
ISSUE: Nano Well-being Health Inc. issued a voluntary recall of Super Arthgold, 500 mg capsules to the consumer level. FDA laboratory analysis has found the product to contain chlorzoxazone,...
FDA Approves Monovisc, a New Single Injection Treatment for Pain Due to Osteoarthritis of the Knee
BEDFORD, Mass., Feb. 25, 2014 --(BUSINESS WIRE)-- Anika Therapeutics, Inc. today announced it has received marketing approval for Monovisc from the U.S. Food and Drug Administration (FDA). Monovisc...
FDA Medwatch Alert: Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients
ISSUE: The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name “WOW.” The pr...
Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine)
NORTHBROOK, IL--(Marketwire - Apr 25, 2011) - Horizon Pharma, Inc., a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis,...
FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain
Indications include osteoarthritis, chronic lower back pain ROCKVILLE, Md., Nov. 4, 2010--The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
prednisone, Cymbalta, ibuprofen, naproxen, meloxicam, aspirin, duloxetine, methylprednisolone, diclofenac, view more... Aleve, Celebrex, Advil, Voltaren, triamcinolone, betamethasone, Medrol, Motrin, cortisone, Excedrin, indomethacin, Mobic, Arthritis Pain, glucosamine, nabumetone